Related Experiment Video
Updated: Aug 10, 2026
08:32
Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
Published on: December 18, 2014
Midazolam disrupts fear memory reconsolidation
S G Bustos1, H Maldonado, V A Molina
1Departamento de Farmacología, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Haya de la Torre y Medina Allende, Ciudad Universitaria, 5000 Córdoba, Argentina.
Neuroscience
|March 18, 2006
Summary
Midazolam (MDZ) disrupts contextual fear memory reconsolidation in rats when given after memory reactivation, but not after initial training. This effect is time-limited and not easily reversed, highlighting MDZ
Area of Science:
- Neuroscience
- Behavioral Neuroscience
- Pharmacology
Background:
- Memory reconsolidation is a crucial process for updating and stabilizing memories.
- GABAergic mechanisms, particularly involving benzodiazepines like midazolam (MDZ), are implicated in memory modulation.
- Understanding how MDZ affects fear memory reconsolidation can inform therapeutic strategies for anxiety disorders.
Purpose of the Study:
- To investigate the effects of midazolam (MDZ) on the reconsolidation of contextual fear memory in a rat model.
- To determine the timing and persistence of MDZ's influence on fear memory formation and retrieval.
- To explore potential methods for reversing MDZ-induced disruptions in fear memory.
Main Methods:
- Rats underwent contextual fear conditioning with three context-shock training trials.
- Midazolam (MDZ) was administered at various time points: post-training, post-reactivation, and at different intervals after reactivation.
- Freezing behavior was assessed upon re-exposure to the training context to measure fear memory.
- Attempts were made to reverse MDZ effects using weak training or unconditioned stimulus reminders.
Main Results:
- Midazolam (MDZ) administration post-reactivation significantly interfered with contextual fear memory formation.
- MDZ administered shortly after initial training did not affect memory formation.
- The disruptive effect of MDZ was observed up to 60 minutes post-reactivation but not later.
- No spontaneous recovery of freezing behavior was noted 11 days post-MDZ, and it was not reverted by weak training or US-alone reminders.
Conclusions:
- Midazolam (MDZ) selectively disrupts the reconsolidation of contextual fear memory, rather than its initial acquisition or retrieval.
- The effect of MDZ on memory reconsolidation is time-dependent, requiring administration shortly after memory reactivation.
- Stimulation of GABA A receptor sites by MDZ plays a critical role in inhibiting the reconsolidation of fear memories.
Related Concept Videos
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:16Repressed Memory
Repressed memories are a psychological phenomenon where memories of traumatic events are unconsciously blocked from a person's awareness. This process occurs as a defense mechanism, protecting the mind from the emotional impact of distressing or painful experiences. For example, a person who has experienced childhood trauma may grow up with no conscious recollection of the event. In such cases, the memories are thought to be buried deep within the subconscious, inaccessible to the conscious...